LMA probably leads to lower failure with primary modality of resuscitation compared with BMV (moderate certainty).
LMA showed no clear difference in death or HIE compared with endotracheal intubation (low certainty).
LMA probably leads to lower need for intubation compared with BMV (moderate certainty).
LMA probably leads to lower apgar score ≤ 7 at 5 minutes compared with BMV (moderate certainty).
LMA probably leads to lower admission to NICU compared with BMV (moderate certainty).
LMA showed no clear difference in death or HIE compared with BMV (low certainty).
It is very uncertain whether LMA changes failure to correctly insert the device compared with endotracheal intubation (very low certainty).
It is very uncertain whether LMA changes successful insertion of device at first attempt compared with endotracheal intubation (very low certainty).
LMA showed no clear difference in apgar score ≤ 7 at 5 minutes compared with endotracheal intubation (low certainty).
LMA showed no clear difference in soft tissue trauma after device inserted compared with endotracheal intubation (low certainty).
Surfactant administration via laryngeal mask airway (S‐LMA) showed no clear difference in death or bronchopulmonary dysplasia compared with surfactant administration via endotracheal tube (ETT) with the… (low certainty).
It is very uncertain whether surfactant administration via laryngeal mask airway (S‐LMA) changes pulmonary air leak, any (during first hospitalisation) Anytime to… compared with surfactant administration via endotracheal tube (ETT) with… (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether surfactant administration via laryngeal mask airway (S‐LMA) changes intraventricular haemorrhage grade III and IV Anytime to discharge compared with surfactant administration via endotracheal tube (ETT) with… (very low certainty).
It is very uncertain whether surfactant administration via laryngeal mask airway (S‐LMA) changes death (all causes) during the first hospitalisation Anytime to… compared with surfactant administration via endotracheal tube (ETT) with… (very low certainty).
The review found no eligible studies for this question.
Surfactant administration via laryngeal mask airway (S‐LMA) showed no clear difference in death or bronchopulmonary dysplasia compared with no surfactant administration (low certainty).
Surfactant administration via laryngeal mask airway (S‐LMA) probably leads to lower mechanical ventilation at any time At any time to discharge compared with no surfactant administration (moderate certainty).
Surfactant administration via laryngeal mask airway (S‐LMA) showed no clear difference in pulmonary air leak, any (during first hospitalisation) Anytime to… compared with no surfactant administration (low certainty).
Surfactant administration via laryngeal mask airway (S‐LMA) showed no clear difference in bronchopulmonary dysplasia (clinical definition) among survivors compared with no surfactant administration (low certainty).